Analyst Ratings for Vaxcyte (PCVX)
PCVX Rating Summary
PCVX Price Target Summary
- Highest: $146.00 (Jefferies)
- Lowest: $67.00 (Goldman Sachs)
- Average: $95.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$95.83 (+61.6%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$95.83 (+61.6%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/12/2025 | Goldman Sachs » Updated 2/26/2026 |
Asad Haider | New Coverage | Neutral (N/A) |
67.00 (38.00) |
33.06 (59.29) |
79.34% | Details |
| 4/22/2025 | Cantor Fitzgerald » Updated 1/23/2026 |
Carter Gould | New Coverage | Overweight (N/A) |
N/A (N/A) |
30.65 (59.29) |
93.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
